SCHEMBL5440973

SCHEMBL5440973

CC(Cl)Oc1csc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
CYP2A6 P11509 3/20 0.39
ALOX5 P09917 1/20 0.38
PKM P14618 1/20 0.37
TUBB4A P04350 2/20 0.36
TUBB P07437 2/20 0.36
TUBA3C P0DPH7 2/20 0.36
TUBA1B P68363 2/20 0.36
TUBA4A P68366 2/20 0.36
TUBB4B P68371 2/20 0.36
TUBB3 Q13509 2/20 0.36
TUBB2A Q13885 2/20 0.36
TUBB8 Q3ZCM7 2/20 0.36
TUBA3E Q6PEY2 2/20 0.36
TUBA1A Q71U36 2/20 0.36
TUBA1C Q9BQE3 2/20 0.36
TUBB6 Q9BUF5 2/20 0.36
TUBB2B Q9BVA1 2/20 0.36
TUBB1 Q9H4B7 2/20 0.36
ERN1 O75460 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7245911 0.85 MAPT (0.44) MAPTCYP2A6ALOX5PKMTUBB4A
SCHEMBL29968024 0.75 TUBB4A (0.51) MAPTCYP2A6PKMTUBB4ATUBB
SCHEMBL6597264 0.75 TUBB4A (0.51) MAPTCYP2A6PKMTUBB4ATUBB
SCHEMBL7112201 0.74 CYP2A6 (0.49) MAPTCYP2A6ALOX5PKMTUBB4A
SCHEMBL11238829 0.71 KMT2A (0.42) TP53ALDH1A1KMT2APTGS1
SCHEMBL32681759 0.71 CYP2A6 (0.45) MAPTCYP2A6PKMTUBB4ATUBB
SCHEMBL23751272 0.69 ALOX5 (0.46) MAPTCYP2A6ALOX5PKMTUBB4A
SCHEMBL367478 0.69 ALOX5 (0.46) MAPTCYP2A6ALOX5PKMTUBB4A
SCHEMBL31721993 0.69 ALOX5 (0.46) MAPTCYP2A6ALOX5PKMTUBB4A
SCHEMBL23751269 0.69 ALOX5 (0.46) MAPTCYP2A6ALOX5PKMTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MAPT 927/4885CYP2A6 264/4885ALOX5 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.